Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 87
Filter
1.
Int J Mol Sci ; 24(1)2022 Dec 30.
Article in English | MEDLINE | ID: mdl-36614084

ABSTRACT

Favism uniquely arises from a genetic defect of the Glucose-6 Phosphate Dehydrogenase (G6PD) enzyme and results in a severe reduction of erythrocytes' (RBCs) reducing power that impairs the cells' ability to respond to oxidative stresses. After exposure to fava beans or a few other drugs, the patients experience acute hemolytic anemia due to RBCs' lysis both intra and extra-vascularly. In the present paper, we compared selected biochemical, biophysical, and ultra-morphological properties of normal RBCs and cells from favism patients measured along cellular aging. Along the aging path, the cells' characteristics change, and their structural and functional properties degrade for both samples, but with different patterns and effectors that have been characterized in biophysical and biochemical terms. In particular, the analysis revealed distinct metabolic regulation in G6DP-deficient cells that determines important peculiarities in the cell properties during aging. Remarkably, the initial higher fragility and occurrence of structural/morphological alterations of favism cells develop, with longer aging times, into a stronger resistance to external stresses and higher general resilience. This surprisingly higher endurance against cell aging has been related to a special mechanism of metabolic regulation that permits lower energy consumption in environmental stress conditions. Our results provided a direct and coherent link between the RBCs' metabolic regulation and the cell properties that would not have been possible to establish without an investigation performed during aging. The consequences of this new knowledge, in particular, can be discussed in a more general context, such as understanding the role of the present findings in determining the characteristics of the favism pathology as a whole.


Subject(s)
Anemia, Hemolytic , Favism , Glucosephosphate Dehydrogenase Deficiency , Vicia faba , Humans , Favism/genetics , Erythrocytes/pathology , Cellular Senescence , Glucosephosphate Dehydrogenase Deficiency/genetics
2.
J Sci Food Agric ; 101(4): 1562-1571, 2021 Mar 15.
Article in English | MEDLINE | ID: mdl-32869306

ABSTRACT

BACKGROUND: Favism is an acute hemolytic syndrome caused by fava bean (FB) ingestion. The purpose of this study was to investigate the possible influences of FB on the metabonomic profile of erythrocytes in glucose-6-phosphate dehydrogenase (G6PD)-deficient (G6PDx) and wild-type (WT) mice. RESULTS: Ninety-two metabolites were identified in the comparison of the G6PDx and WT groups. Eighty-seven metabolites were identified in the erythrocytes of WT and G6PDx mice after FB ingestion. Thirty-eight metabolites were identified in the comparison of the FB-treated G6PDx and the FB-treated WT mouse groups. Among them, the number of glycerophospholipids (GPLs) and polyunsaturated fatty acids (PUFAs) changed significantly, which suggests that GPLs and PUFAs may be responsible for FB stress. CONCLUSION: This study demonstrates that G6PD deficiency might affect the metabonomic profile of erythrocytes in response to FB. © 2020 Society of Chemical Industry.


Subject(s)
Erythrocytes/metabolism , Favism/metabolism , Glucosephosphate Dehydrogenase Deficiency/metabolism , Vicia faba/metabolism , Animals , Erythrocytes/enzymology , Fatty Acids, Unsaturated/metabolism , Favism/enzymology , Favism/genetics , Glucosephosphate Dehydrogenase Deficiency/enzymology , Glucosephosphate Dehydrogenase Deficiency/genetics , Glycerophospholipids/metabolism , Humans , Male , Metabolomics , Mice , Mice, Inbred C3H , Mice, Knockout
3.
J Clin Lab Anal ; 34(9): e23402, 2020 Sep.
Article in English | MEDLINE | ID: mdl-32557798

ABSTRACT

BACKGROUND: Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common human enzymopathy. The human G6PD gene is highly polymorphic, and over 200 mutations have been identified, many of which are associated with hemolytic anemia. Here, we analyzed the clinical genetics data of a Chinese girl with favism who developed acute hemolytic anemia after fava bean ingestion. METHODS: The clinical genetics data of the proband who developed acute hemolytic anemia were collected and analyzed, and G6PD gene exons were sequenced in the proband and her family. RESULTS: We reported for the first time a novel G6PD gene variant in a Chinese girl, which we named "G6PD Wuhan." This variant is localized exon 3 of the G6PD gene at genomic position 141G > C, that is a change from p.Lys47 to Asn. The bioinformatics analysis and protein modeling study indicated this variant may have negative effects on the enzyme activity of G6PD. CONCLUSIONS: Our results indicated that favism in the proband was caused by this novel heterozygous variant (c.141G > C) in G6PD. The variant in G6PD has implications for genetic counseling and could provide insights into the functional roles of G6PD mutations.


Subject(s)
Asian People/genetics , Favism/genetics , Favism/pathology , Glucosephosphate Dehydrogenase/genetics , Mutation , Child, Preschool , Female , Humans , Prognosis
5.
Gene ; 652: 66-77, 2018 Apr 30.
Article in English | MEDLINE | ID: mdl-29428800

ABSTRACT

Favism is an acute hemolytic syndrome caused by the ingestion of fava bean (FB) in glucose 6-phosphate dehydrogenase (G6PD) deficient individuals. However, little is known about the global transcripts alteration in liver tissue after FB ingestion in G6PD-normal and -deficient states. In this study, deep sequencing was used to analyze liver genes expression alterations underlying the effects of FB in C3H (Wild Type, WT) and G6PD-deficient (G6PDx) mice and to evaluate and visualize the collective annotation of a list of genes to Gene Ontology (GO) terms associated with favism. Our results showed that FB resulted in a decrease of glutathione (GSH)-to-oxidized glutathione (GSSG) ratio and an increase of malondialdehyde (MDA) both in the G6PDx and WT-control check (CK) mice plasma. Significantly, liver transcript differences were observed between the control and FB-treated groups of both WT and G6PDx mice. A total of 320 differentially expressed transcripts were identified by comparison of G6PDx-CK with WT-CK and were associated with immune response and oxidation-reduction function. A total of 149 differentially expressed genes were identified by comparison of WT-FB with WT-CK. These genes were associated with immune response, steroid metabolic process, creatine kinase activity, and fatty acid metabolic process. A total of 438 differential genes were identified by comparing G6PDx-FB with G6PD-CK, associated with the negative regulation of fatty acid metabolic process, endoplasmic reticulum, iron binding, and glutathione transferase activity. These findings indicate that G6PD mutations may affect the functional categories such as immune response and oxidation-reduction.


Subject(s)
Favism/genetics , Glucosephosphate Dehydrogenase Deficiency/genetics , Liver/drug effects , Transcriptome , Vicia faba/toxicity , Animals , Favism/complications , Favism/immunology , Favism/pathology , Gene Expression Profiling , Gene Expression Regulation , Gene Ontology , Glucosephosphate Dehydrogenase Deficiency/complications , Glucosephosphate Dehydrogenase Deficiency/immunology , Glucosephosphate Dehydrogenase Deficiency/pathology , Glutathione/blood , High-Throughput Nucleotide Sequencing , Immunity, Innate , Liver/metabolism , Male , Malondialdehyde/blood , Mice , Mice, Inbred C3H , Mice, Knockout , Molecular Sequence Annotation , Oxidation-Reduction , Oxidative Stress/drug effects , Plant Extracts/toxicity , Vicia faba/chemistry
6.
Ugeskr Laeger ; 179(20)2017 May 15.
Article in Danish | MEDLINE | ID: mdl-28504635

ABSTRACT

A three-year-old Syrian boy was hospitalized with symptoms of acute haemolytic anaemia after ingestion of fava beans. He was stabilized by blood transfusion, and genetic examination revealed glucose-6-phosphate dehydrogenase (G6PD) deficiency. Oxidative stress, e.g. ingestion of fava beans, can induce acute haemolytic anaemia in affected individuals. Approximately 400 million people worldwide suffer from G6PD deficiency. The prevalence is high in African, Mediterranean and Middle East countries. Due to increased immigration, we might expect the condition to occur more often in Danish healthcare.


Subject(s)
Favism/etiology , Vicia faba/adverse effects , Child, Preschool , Denmark , Favism/genetics , Favism/therapy , Glucosephosphate Dehydrogenase Deficiency/diagnosis , Glucosephosphate Dehydrogenase Deficiency/genetics , Humans , Male , Syria/ethnology
8.
Pediatr. aten. prim ; 18(72): 349-354, oct.-dic. 2016. tab
Article in Spanish | IBECS | ID: ibc-158712

ABSTRACT

El déficit de glucosa-6-fosfato-deshidrogenasa es la enzimopatía más frecuente de los glóbulos rojos. Se trata de una enfermedad ligada al cromosoma X que afecta preferentemente a varones. La prevalencia es de alrededor de 400 millones de personas en el mundo. Pese a esto, se considera una enfermedad "huérfana" en tratamientos y actos médicos necesarios, como la anestesia. Presentamos el caso de un paciente afecto de esta mutación y su periplo por distintas especialidades para lograr una extracción dentaria con anestesia local (AU)


Glucose 6-phosphate-dehydrogenase deficiency is the most common enzymatic disease of red blood cells. This is an X-linked disorder that mainly affects males. The prevalence is about 400 million people worldwide. Despite of this, it is considered an orphan disease in some treatments and medical procedures such as anesthesia. We describe the case of a 9-year-old male patient affected by this mutation and his travel around different specialists in order to achieve a dental extraction under local anesthesia (AU)


Subject(s)
Humans , Male , Child , Glucosephosphate Dehydrogenase Deficiency/complications , Glucosephosphate Dehydrogenase Deficiency/diagnosis , Anesthesia, Local , Favism/complications , Favism/genetics , Bupivacaine/therapeutic use , Neonatal Screening/methods , Neonatal Screening , Primary Health Care , X Chromosome , X Chromosome/genetics
9.
Blood Cells Mol Dis ; 60: 58-64, 2016 09.
Article in English | MEDLINE | ID: mdl-27519946

ABSTRACT

Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a common genetic abnormality known to predispose to acute hemolytic anemia (AHA), which can be triggered by certain drugs or infection. However, the commonest trigger is fava beans (Vicia faba) ingestion, causing AHA (favism), which may be life-threatening especially in children. G6PD deficiency is genetically highly heterogeneous, as nearly 200 different mutations have been observed. We have investigated the hematological features of acute favism in the Palestinian Gaza community that is characterized by the polymorphic coexistence of three different G6PD deficiency genes (G6PD A-, G6PD Cairo, G6PD Med). We have found by comparison to the general population (485 adults and 466 newborns) that children with favism, in terms of relative frequency, G6PD A- was under-represented, whereas G6PD Med was over-represented. We also found that the severity of anemia was significantly greater with G6PD Med and G6PD Cairo than with G6PD A-; and with G6PD Cairo, compared to the other two variants, there was greater hyperbilirubinemia, as well as persistence of mild anemia and reticulocytosis for as long as 4months after recovery from favism. This is the first report determining a differential impact of different G6PD mutations on the clinical features of favism in the same population and the same environment.


Subject(s)
Favism/genetics , Genetic Variation , Glucosephosphate Dehydrogenase Deficiency/genetics , Anemia, Hemolytic/genetics , Anemia, Hemolytic/pathology , Arabs , Blood Specimen Collection , Child , Child, Preschool , Female , Glucosephosphate Dehydrogenase , Glucosephosphate Dehydrogenase Deficiency/pathology , Humans , Male , Sequence Analysis, DNA
10.
Eur Rev Med Pharmacol Sci ; 18(19): 2821-7, 2014 Oct.
Article in English | MEDLINE | ID: mdl-25339475

ABSTRACT

OBJECTIVES: Identify and screen the G6PD Mediterranean mutation in favism patients by applying a Amplification Refractory Mutation System Polymerase Chain Reaction (ARMS-PCR). PATIENTS AND METHODS: A total of 114 unrelated Egyptians patients were included in the present study; their ages ranged between (2-9) years with male to female ratio 4.5:1. G6PD activity was determined qualitatively from red cell hemolysate during attack. The G6PD Mediterranean mutation in patients has been identified by ARMS-PCR. RESULTS: G6PD deficiency was detected in 87.7%, (n=100). The frequency of G6PD Mediterranean mutation was (94.7%), (n=108). The association between G6PD deficiency and Mediterranean mutation was a highly significant. CONCLUSIONS: Glucose-6-phosphate dehydrogenase Mediterranean mutation is one of the most common mutations causing G6PD deficiency among Egyptian children with favism.


Subject(s)
Favism/genetics , Glucosephosphate Dehydrogenase/genetics , Mutation , Case-Control Studies , Child , Child, Preschool , Egypt , Favism/enzymology , Female , Glucosephosphate Dehydrogenase/blood , Glycation End Products, Advanced , Humans , Male , Polymerase Chain Reaction/methods
12.
Hematol Oncol Stem Cell Ther ; 6(1): 9-13, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23664599

ABSTRACT

BACKGROUND AND OBJECTIVES: The etiology of favism remains unclear and the fate of favic patients has not previously been studied. Therefore, individuals who had experienced an episode of favism were studied regarding subsequent fava bean ingestion, including the reason for fava bean ingestion after the initial favic attack and any adverse reactions. In addition, a new hypothesis for the etiology of favism is proposed. PATIENTS AND METHODS: From June 2005 to June 2012, a total of 38 patients with a history of favism were included in this study. Circumstances regarding the initial favic attack were obtained from medical records and patient interviews, and subsequent fava bean ingestion and recurrence of symptoms were investigated. RESULTS: Three of the 38 patients (7.9%) were female, and 35 (92.1%) were male. The mean age was 27.9 years (14-63 years). The first attack of favism occurred before 10 years of age for 31 patients (81.6%) and in the springtime for 35 patients (92.1%). Thirty-three patients (86.7%) regularly ate fava beans before the attack, and 35 (92.1%) resumed eating fava beans within 1-17 years after the attack without symptoms. Two patients (5.2%) experienced a single recurrence of symptoms. No evidence of hemolysis was found in the four patients checked after fava bean re-ingestion. CONCLUSIONS: Patients resumed eating fava bean for various reasons, and the recurrence of symptoms was uncommon. An infectious agent such as a virus may play a role in the development of favism.


Subject(s)
Favism/etiology , Vicia faba/adverse effects , Adolescent , Adult , Eating , Favism/diagnosis , Favism/genetics , Female , Glucosephosphate Dehydrogenase/genetics , Glucosephosphate Dehydrogenase/metabolism , Humans , Interviews as Topic , Male , Middle Aged , Pollen/adverse effects , Recurrence , Retrospective Studies , Seasons , Young Adult
13.
J Nephrol ; 25(4): 582-5, 2012.
Article in English | MEDLINE | ID: mdl-22307442

ABSTRACT

Fabry disease is an X-linked lysosomal disease caused by mutations of the alpha-galactosidase A (GLA) gene at chromosome subband Xq22.1. To date, more than 600 genetic mutations have been identified to determine the nature and frequency of the molecular lesions causing the classical and milder variant phenotypes and for precise carrier detection. We report here a Fabry family (mother, son and daughter) where the alpha-galactosidase A defect was associated with a glucose-6-phosphate dehydrogenase (G6PD) deficiency. Mutation analysis revealed for the GLA gene the presence of a new mutation, i.e., a small deletion (c.452delA) on exon 3 and for the G6PD gene the presence of 2 mutations, p.V68M (G6PD Asahi, G6PD A+) and p.N126D (G6PD A+) on exon 3 and exon 4, respectively.


Subject(s)
Fabry Disease/genetics , Glucosephosphate Dehydrogenase Deficiency/genetics , Glucosephosphate Dehydrogenase/genetics , Sequence Deletion , alpha-Galactosidase/genetics , Adolescent , DNA Mutational Analysis , Enzyme Replacement Therapy , Exons , Fabry Disease/diagnosis , Fabry Disease/drug therapy , Fabry Disease/enzymology , Favism/genetics , Female , Genetic Predisposition to Disease , Glucosephosphate Dehydrogenase Deficiency/diagnosis , Glucosephosphate Dehydrogenase Deficiency/enzymology , Humans , Isoenzymes/therapeutic use , Male , Middle Aged , Pedigree , Phenotype , Young Adult , alpha-Galactosidase/therapeutic use
14.
Genet Mol Res ; 10(2): 878-84, 2011 May 17.
Article in English | MEDLINE | ID: mdl-21644204

ABSTRACT

An association between favism (a hemolytic reaction to consumption of fava beans), glucose-6-phosphate dehydrogenase deficiency (G6PD(-)) and acid phosphatase locus 1 (ACP(1)) phenotypes has been reported; the frequency of carriers of the p(a) and p(c) ACP(1) alleles was found to be significantly higher in G6PD(-) individuals showing favism than in the general population. Here, we investigated the hypothesis that favism is caused by toxic Vicia faba substances, which in some ACP(1) phenotypes cause increased phosphorylation and consequently increased glycolysis, with strong reduction in reduced glutathione production, resulting in hemolysis. It has been demonstrated that ACP(1) f isoforms have physiological functions different from those of s isoforms and are responsible for most of the phosphatase activity, in addition to being less stable in the presence of oxidizing molecules. Thus, the C, CA and A phenotypes, characterized by lower concentrations of f isoforms, could be more susceptible to damage by oxidative events compared to the other phenotypes. To test this hypothesis, the (f+s) enzymatic activity of different ACP(1) phenotypes with and without added V. faba extract was analyzed. Enzymatic activities of ACP(1) A, -CA, -C groups (low activity) and -B, -BA, -CB groups (high activity) were significantly different after addition of V. faba extract. Phenotypes A, CA and C had extremely low enzymatic activity levels, which would lead to low levels of reduced glutathione and bring about erythrocyte lysis.


Subject(s)
Favism/genetics , Polymorphism, Genetic , Protein Tyrosine Phosphatases/genetics , Proto-Oncogene Proteins/genetics , Favism/enzymology , Glucosephosphate Dehydrogenase Deficiency/genetics , Humans
15.
Ned Tijdschr Geneeskd ; 155: A2020, 2011.
Article in Dutch | MEDLINE | ID: mdl-21447212

ABSTRACT

A 1-year-old Moroccan boy was referred because of jaundice. A peripheral blood smear showed 'blister cells'. This finding is characteristic for haemolysis caused by glucose-6-phosphate dehydrogenase deficiency. It appeared hemolysis occurred because the boy ate fava beans.


Subject(s)
Glucosephosphate Dehydrogenase Deficiency/diagnosis , Glucosephosphate Dehydrogenase/genetics , Favism/complications , Favism/diagnosis , Favism/enzymology , Favism/genetics , Glucosephosphate Dehydrogenase/blood , Glucosephosphate Dehydrogenase Deficiency/complications , Glucosephosphate Dehydrogenase Deficiency/enzymology , Glucosephosphate Dehydrogenase Deficiency/genetics , Hemolysis , Humans , Infant , Jaundice/diagnosis , Jaundice/etiology , Male , Morocco/ethnology , Netherlands
16.
J Coll Physicians Surg Pak ; 20(12): 794-7, 2010 Dec.
Article in English | MEDLINE | ID: mdl-21205543

ABSTRACT

OBJECTIVE: To evaluate the G6PD(C563T) Mediterranean mutation among Jordanian females who were admitted to Princess Rahma Teaching Hospital (PRTH) with/or previous history of favism. STUDY DESIGN: A descriptive study. PLACE AND DURATION OF STUDY: Jordanian University of Science and Technology and PRTH, from October 2003 to October 2004. METHODOLOGY: After obtaining approval from the Ethics Committee of Jordanian University of Science and Technology, a total of 32 females were included in this study. Samples from 15 healthy individual females were used as a negative control. Blood samples from these patients were collected and analyzed by allele-specific polymerase chain reaction (AS-PCR) to determine the G6PD(C563T) mutation. RESULTS: Twenty one out of 32 patients were found to be G6PD(C563T) Mediterranean mutation (65.6%) positive. Three out of 21 patients were homozygous and remaining 18 were heterozygous for G6PD(C563T) Mediterranean mutation. Eleven (34.4%) out of 32 patients were found to be negative for G6PD(C563T) mutation indicating the presence of other G6PD mutations in the study sample. CONCLUSION: G6PD(C563T) Mediterranean mutation accounted for 65.6% of the study sample with favism in the North of Jordan. There is likely to be another G6PD deficiency variant implicated in acute hemolytic crisis (favism).


Subject(s)
Favism/genetics , Glucosephosphate Dehydrogenase Deficiency/genetics , Glucosephosphate Dehydrogenase/genetics , Hemolysis/genetics , Mutation , Acute Disease , Favism/complications , Female , Glucosephosphate Dehydrogenase Deficiency/complications , Humans , Jordan
18.
Eur J Pediatr ; 168(7): 779-82, 2009 Jul.
Article in English | MEDLINE | ID: mdl-19263080

ABSTRACT

INTRODUCTION: Reduced concentrations of glucose-6-phospate dehydrogenase (G6PD) render erythrocytes susceptible to hemolysis under conditions of oxidative stress. In favism, the ingestion of fava beans induces an oxidative stress to erythrocytes, leading to acute hemolysis. DISCUSSION: The simultaneous occurrence of methemoglobinemia has been reported only scarcely, despite the fact that both phenomena are the consequence of a common pathophysiologic mechanism. The presence of methemoglobinemia has important diagnostic and therapeutic consequences. We report a previously healthy boy who presented with combined severe hemolytic anemia and cyanosis due to methemoglobinemia, following the ingestion of fava beans. His condition was complicated by the development of transient acute renal failure. A G6PD-deficiency was diagnosed. We review the literature on the combination of acute hemolysis and methemoglobinemia in favism. Pathophysiologic, diagnostic, and therapeutic aspects of this disorder are discussed.


Subject(s)
Glycogen Storage Disease Type I/diagnosis , Glycogen Storage Disease Type I/physiopathology , Hemolysis , Methemoglobinemia/complications , Methemoglobinemia/etiology , Vicia faba/adverse effects , Acute Kidney Injury/etiology , Acute Kidney Injury/physiopathology , Cyanosis/etiology , Cyanosis/physiopathology , Favism/enzymology , Favism/genetics , Glycogen Storage Disease Type I/therapy , Humans , Infant , Male , Methemoglobinemia/physiopathology , Risk Factors
19.
J Cardiovasc Med (Hagerstown) ; 9(11): 1159-62, 2008 Nov.
Article in English | MEDLINE | ID: mdl-18852594

ABSTRACT

We describe the case of a 64-year-old patient with glucose-6-phosphate dehydrogenase deficiency who was referred to our hospital because of an acute inferior myocardial infarction.Given the possible risk of acute haemolytic anaemia, aspirin was not given in the acute phase, and the patient was successfully treated by balloon angioplasty of the right coronary artery.After functional and genetic testing showing the presence of the Mediterranean mutation, known to be a class II variant, the patient received oral daily aspirin (100 mg) under strict monitoring in order to promptly detect any sign of haemolysis. After 4 days, a complex percutaneous coronary intervention with an implantation of two drug-eluting stents was successfully performed on the left coronary artery. After 3 months, the patient is free from adverse events.Glucose-6-phosphate dehydrogenase deficiency is commonly considered a contraindication to aspirin intake; however, this case shows that aspirin at low, antiplatelet dosage is well tolerated and should not be denied to patients with ischaemic heart disease and complex coronary anatomy.


Subject(s)
Anemia, Hemolytic/chemically induced , Angioplasty, Balloon, Coronary/instrumentation , Aspirin/adverse effects , Drug-Eluting Stents , Favism/complications , Myocardial Infarction/therapy , Platelet Aggregation Inhibitors/adverse effects , Administration, Oral , Anemia, Hemolytic/genetics , Angioplasty, Balloon, Coronary/adverse effects , Aspirin/administration & dosage , Coronary Angiography , Favism/enzymology , Favism/genetics , Glucosephosphate Dehydrogenase/genetics , Humans , Male , Middle Aged , Mutation , Myocardial Infarction/complications , Myocardial Infarction/diagnostic imaging , Myocardial Infarction/drug therapy , Platelet Aggregation Inhibitors/administration & dosage , Risk Assessment , Treatment Outcome
20.
J Hum Genet ; 53(7): 675-679, 2008.
Article in English | MEDLINE | ID: mdl-18452027

ABSTRACT

Glucose-6-phosphate dehydrogenase (G6PD) deficiency in Africa is of high prevalence, although precise data are lacking in many individual nations. We investigated 129 unrelated subjects (71 male subjects, 58 female subjects) visiting a teaching hospital in Freetown, Sierra Leone, to collect baseline data on the distribution of G6PD deficiency among respective ethnic groups in the country. We confirmed eight G6PD-deficient male subjects by two formazan-based blood tests (11.3% of the male subjects examined), and also detected the common 376A > G mutation in 11 male subjects and eight female subjects by sequencing exons 3-5 of the G6PD gene. Selected samples were further sequenced for exons 2-13 and introns 5, 7, 8, and 11. Among the deficient male subjects, six were G6PD A- carrying the double mutations (202G > A and 376A > G), all of whom were in the Temne and Mende ethnic groups. Others included A- Betica, and a novel variant having double mutations in exon 5 (311G > A and 376A > G forming 104 Arg > His and 126 Asn > Asp, respectively), which we designate as G6PD Sierra Leone. Subsequent haplotype analysis linked this novel variant to the G6PD A- "family".


Subject(s)
Genetic Heterogeneity , Glucosephosphate Dehydrogenase Deficiency/enzymology , Glucosephosphate Dehydrogenase Deficiency/genetics , Glucosephosphate Dehydrogenase/genetics , Adolescent , Amino Acid Substitution/genetics , Child, Preschool , Favism/genetics , Female , Glucosephosphate Dehydrogenase/biosynthesis , Glucosephosphate Dehydrogenase Deficiency/epidemiology , Glucosephosphate Dehydrogenase Deficiency/ethnology , Humans , Male , Molecular Sequence Data , Point Mutation , Polymorphism, Single Nucleotide , Prevalence , Sierra Leone/epidemiology , Sierra Leone/ethnology
SELECTION OF CITATIONS
SEARCH DETAIL
...